Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in California | 1,207 Studies

Clinical Trials LymphomaCalifornia

Lymphoma Clinical Trials in California

Find 1,207 clinical trials for lymphoma near California. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 1,207 trials

CompletedDexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaThis randomized phase III trial is studying dexamethasone to see how well it works compared to prednisone during induction therapy.NCT00075725·Birmingham, Alabama and 233 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedIrinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the PelvisRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003368·Birmingham, Alabama and 44 others

CompletedA Standardized Nursing Intervention Protocol for HCT PatientsRATIONALE: Visiting patients at home to teach them about self care after a stem cell transplant may be more effective than standard therapy in improving quality of life.NCT00951626·Duarte, California

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348140·Sun City, Arizona and 193 others

TerminatedA Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsThis study is a dose escalation, and cohort expansion study in subjects with advanced cancer for which no standard therapy exists.NCT02440685·Tempe, Arizona and 13 others

CompletedStudy of Efficacy and Safety of CTL019 in Pediatric ALL PatientsThis is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of CTL019 in pediatric patients with r/r B-cell ALL.NCT02435849·Los Angeles, California and 22 others

CompletedA Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyThis study will provide continuing availability to tazemetostat for people that have previously completed participation in a tazemetostat study, either with monotherapy (single…NCT02875548·Tucson, Arizona and 33 others

CompletedDose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid MalignanciesA two part, Phase 1b/2 study to define a recommended Phase 2 dose of VRx-3996 in combination with valganciclovir (Phase 1b) designed to evaluate the efficacy of this combination…NCT03397706·Los Angeles, California and 27 others

RecruitingSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesThis is a prospective, multicenter, open-label, single-arm study to assess the efficacy, safety, and pharmacokinetics (PK) of IgPro20 in adults with hematologic malignancies…NCT07648264·Orange, California and 59 others

CompletedBendamustine Hydrochloride in Combination With Rituximab in Patients With Relapsed Refractory Mantle Cell LymphomaThe purpose of this study is to determine the efficacy and safety of the combination of bendamustine and rituximab in patients with relapsed/refractory mantle cell lymphoma.NCT00891839·Fountain Valley, California and 12 others

RecruitingA Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )The purpose of this study is to find the best dose of the drug and measure the safety and efficacy of LY4152199 in participants with previously treated B-cell malignancies.NCT07101328·Duarte, California and 50 others

TerminatedA Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal AntibodiesThe main purpose of this study is to determine the best dose of MEDI6469 that is safe and tolerable when given as monotherapy and in combination with tremelimumab, MEDI4736…NCT02205333·Scottsdale, Arizona and 12 others

RecruitingFecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T CellsThis phase II trial tests how well fecal microbiome transplantation works to remodel intestinal microbiota for patients with lymphoma that has come back after a period of…NCT07042438·Duarte, California

Active not recruitingVenetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic LeukemiaThis phase I trial tests the safety, side effects, and best dose of venetoclax in combination with a pediatric-inspired chemotherapy regimen known as C10403 in treating patients…NCT05157971·Duarte, California

CompletedVenetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell LymphomaThis phase II trial studies the side effects and best dose of venetoclax and romidepsin to see how well it works in treating patients with mature T-cell lymphoma that has come…NCT03534180·Duarte, California and 1 other

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors…NCT03155620·Birmingham, Alabama and 171 others

CompletedA Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693Subcutaneous administration of AZD2693 single dose in participants with hepatic impairmentNCT05919069·Rialto, California and 2 others

CompletedA Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal ImpairmentThe objective of this study is to assess and compare the pharmacokinetic properties of YM178 in normal subjects and those with mild, moderate and severe renal impairment.NCT00750620·Anaheim, California and 1 other

CompletedIbrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic LeukemiaThis phase II trial studies how well ibrutinib and blinatumomab work in treating patients with B acute lymphoblastic leukemia that has come back or is not responding to treatment.NCT02997761·Los Angeles, California and 1 other

UnknownStudy of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationThe goal of this clinical research study is to learn if it is safe and feasible to transplant patients with one of two units of cord blood that has been changed in the laboratory…NCT01983761·La Jolla, California and 3 others

PreviousPage 7 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia